EDGAR Filing Documents for 0001193125-19-086862

Form CORRESP - Correspondence:

SEC Accession No. 0001193125-19-086862

Filing Date

2019-03-26

Accepted

2019-03-26 18:31:32

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		filename1.htm	CORRESP	64410
2	GRAPHIC	g929192g0327002554667.jpg	GRAPHIC	2536
	Complete submission text file	0001193125-19-086862.txt		69166

Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 225 SAN DIEGO CA 92121

Business Address 10628 SCIENCE CENTER DRIVE, SUITE 225 SAN DIEGO CA 92121 858-926-5251

Turning Point Therapeutics, Inc. (Filer) CIK: 0001595893 (see all company filings)

IRS No.: 463826166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations